FIELD: medicine, in particular composition for treatment and/or prevention of inflammation condition.
SUBSTANCE: claimed composition contains anti-inflammation agent and optionally other active agents, water dispersible and ethanol insoluble amphipathic oil, microcrystalline wax and pharmaceutically acceptable non-aqueous carrier. Method for treatment includes administering of said composition in organ.
EFFECT: agent with increased oxidative stability, low interface tensile and reduced side effects.
65 cl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DISPERSIBLE PHARMACEUTICAL COMPOSITIONS | 2003 |
|
RU2311201C2 |
| METHOD AND PHARMACEUTICAL COMPOSITION FOR ANTIPHLOGISTIC AGENT DELIVERY | 2004 |
|
RU2325189C2 |
| SOLUBLE PHARMACEUTICAL COMPOSITION FOR MASTITIS AND EAR INVOLVEMENT TREATMENT | 2004 |
|
RU2329064C2 |
| DISPERSIBLE PHARMACEUTICAL COMPOSITION FOR TREATMENT OF MASTITIS AND OTIC DISORDERS | 2004 |
|
RU2321423C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING MODIFIED CARRIER | 2003 |
|
RU2401127C2 |
| METHODS OF TREATING MICROBIAL INFECTIONS, INCLUDING MASTITIS | 2014 |
|
RU2662300C2 |
| METHODS FOR MEASUREMENT OF DISSOLVING RATE OF ANALYZED SUBSTANCE IN NONAQUEOUS LIQUID COMPOSITION | 2003 |
|
RU2300766C2 |
| COMPOSITIONS AND METHOD OF CONTROLLING INFECTIONS IN NON-HUMAN MAMMALS USING ACUTE PHASE PROTEINS | 2014 |
|
RU2725841C2 |
| NOVEL SALT AND MEDICAL APPLICATION | 2012 |
|
RU2609011C2 |
| COMPOSITIONS WITH CONTROLLED RELEASE AND METHODS OF THEIR USE | 2013 |
|
RU2627429C2 |
